Engineers Gate Manager LP - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$2,448,386
-2.5%
47,003
+18.5%
0.09%
-4.2%
Q2 2023$2,511,778
+834.3%
39,668
+699.0%
0.10%
+763.6%
Q1 2023$268,855
-34.0%
4,965
-35.5%
0.01%
-54.2%
Q4 2022$407,061
-58.2%
7,692
-63.2%
0.02%
-60.7%
Q3 2022$974,000
-58.0%
20,923
-48.5%
0.06%
-28.2%
Q2 2022$2,317,000
+554.5%
40,594
+602.0%
0.08%
+507.1%
Q1 2022$354,000
-68.8%
5,783
-79.2%
0.01%
-80.8%
Q2 2021$1,135,000
+451.0%
27,816
+247.0%
0.07%
+630.0%
Q3 2020$206,000
-41.1%
8,015
-21.4%
0.01%
-33.3%
Q4 2019$350,000
+15.9%
10,200
-74.7%
0.02%0.0%
Q3 2019$302,000
+70.6%
40,390
+195.4%
0.02%
+50.0%
Q2 2019$177,000
-69.5%
13,672
-71.3%
0.01%
-71.4%
Q1 2019$581,000
+68.9%
47,678
+57.7%
0.04%
+25.0%
Q4 2018$344,000
-75.4%
30,241
-54.4%
0.03%
-69.9%
Q1 2018$1,396,000
+227.7%
66,308
+125.5%
0.09%
+220.7%
Q4 2017$426,00029,4010.03%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 700,000$42,833,0008.57%
SILVERARC CAPITAL MANAGEMENT, LLC 308,819$18,897,0007.82%
Vahanian & Associates Financial Planning Inc. 45,533$2,786,0006.44%
DCF Advisers, LLC 238,500$14,594,0006.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 50,956$20,930,0004.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,531,923$93,738,0002.86%
Nicholas Investment Partners, LP 562,373$34,412,0002.45%
Bellevue Group AG 3,429,619$209,859,0002.44%
WASATCH ADVISORS LP 7,477,868$457,571,0002.25%
Quantum Private Wealth, LLC 73,772$4,514,0001.95%
View complete list of INTRA CELLULAR THERAPIES INC shareholders